Menu ×

HEALTHCARE & PHARMACEUTICAL

Advanced Wound Care Market Segmentation By Product (Infection Management, Active Wound Care, Wound Therapy Devices and Exudate Management); By Wound Type (Ulcers, Surgical Wounds, Burns, Traumatic Wounds and Others); By End User (Hospitals & Clinics, Home Care Settings and Others) – Global Demand Analysis and Opportunity Outlook 2028

  • Text Size:

Extensive insights into the Growth of Advanced Wound Care Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More
IN THE NEWS

May 15, 2019: Researchers in Indiana University discovered a method to fight bacterial infections using electricity. They developed a dressing which uses electric fields to disrupt a wound’s bio film growth.

Introduction

Wound healing involves restoration of tissue, on its own after the injury. Some metabolic conditions caused by chronic diseases and other factors could hamper the healing process leading to chronic and non-healing wounds. In the current scenario, as more people suffer from non-healing wounds, it would be extremely necessary for the advanced wound care industry to develop innovative technologies to solve complications arising out of chronic wounds. With rising per capita income in the developed and developing regions of the world coupled with unhealthy lifestyle, the prevalence of chronic diseases is increasing every year. Additionally, prevalence of chronic wounds and infections has increased due to rise in the population with comorbidities. For an effective treatment, general practitioners are not qualified enough to understand chronic wound. However, advanced wound care professionals are extensively trained and specialized for treating chronic wound healing. Hence, advanced wound care is necessary for not just healing but also to prevent future complications such as amputations. It can significantly enhance a patient’s quality of life. It has therefore become increasingly popular among medical professionals.

Market Size and Forecast

The global advanced wound care market is expected to attain a robust CAGR during the forecast period i.e., 2020-2028. This can be attributed to rising number of road accidents resulting in injuries, prevalence of diabetes and increasing research and development activities pertaining to wound care around the globe.  The market is segmented by product, wound type, end user and region. The product segment is further segmented into infection management, active wound care, wound therapy devices and exudate management, out of which, the active wound care segment is anticipated to grow at the fastest rate on account of rising chronic diseases such as diabetes mellitus, obesity, and elderly population that is more prone to chronic wounds and infections.

Growth Drivers

Rising Prevalence of Chronic Diseases & Growing Demand for Evidence-Based Approach Towards Treating Wounds

Rising per capita income and sedentary lifestyle in the developing and developed countries has led to an increase in chronic diseases such as diabetes mellitus and various kinds of ulcers. Due to high prevalence of such diseases, chances of wound infections with slower recovery also increases. Moreover, some developing countries following traditional wound care practices are now looking to adopt the advanced wound care practices. Additionally, people are becoming more inclined towards evidence-based treatments with higher accuracy as compared to conventional methods. These are some of the significant factors contributing to the growth of the market. CLICK TO DOWNLOAD SAMPLE REPORT

Increasing Research and Development Activities

Advanced wound care is showing promising results in its initial stages in treatment of chronic wounds. Extensive research and development activities being carried out by the government organizations and research universities are estimated to exhibit notable opportunities for market growth over the forecast period.

Restraints

High Cost of Treatment

Lack of awareness and high cost associated with the advanced wound care treatment is estimated to adversely affect the growth of the market over the forecast period.

Market Segmentation

Our in-depth analysis of the global advanced wound care market includes the following segments:

By Product:

  • Infection Management
  • Active Wound Care
  •  Therapy Devices
  • Exudate Management

By Wound Type:

  • Ulcers
  • Surgical Wounds
  • Burns
  • Traumatic Wounds
  • Others

By End User:

  • Hospitals & Clinics
  • Home Care Settings
  • Others

By Region:

On the basis of regional analysis, the global advanced wound care market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Among these regions, the market in North America is anticipated to hold the largest market share on the back of availability of major key players in the region, increasing geriatric population and numerous initiatives taken by authoritative bodies to raise awareness regarding the efficacy of advanced wound care treatment and associated products. Additionally, availability of advanced services and trained professionals is contributing to the growth of the market in the region.

The advanced wound care market in Asia Pacific is projected to witness fastest growth owing to growing population and rising disposable income that is driving people towards advanced wound care treatment. This growth if closely trailed by the market in Europe owing to rising geriatric population in the region.

The global advanced wound care market is further classified on the basis of regions as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis.

Top featured companies dominating the market

3M Company

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis

Hill-Rom Holdings, Inc.

B. Braun Melsungen AG

Acelity L.P. Inc.

BSN Medical GmbH

Cardinal Health, Inc.

Celularity, Inc.

Paul Hartmann AG

Organogenesis

Smith & Nephew

Medtronic PLC

Medline Industries, Inc.

Hollister Incorporated

Integra LifeSciences Holdings Corporation

Johnson & Johnson

Lohmann & Rauscher GmbH & Co. Kg

Coloplast A/S

 


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved